Related Experiment Video
Updated: Mar 1, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.4K
Systemic Treatments in Soft Tissue Sarcomas
H Hatcher1, C Benson2, T Ajithkumar1
1Cambridge University Hospitals, Cambridge, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|May 30, 2017
Summary
Systemic treatment for adult soft tissue sarcoma is evolving. While its use before surgery (neoadjuvant) is experimental and after surgery (adjuvant) inconclusive, chemotherapy can be considered individually for advanced or metastatic cases.
Area of Science:
- Oncology
- Medical treatment of soft tissue sarcoma
Background:
- Systematic treatment for adult-type soft tissue sarcoma is undergoing significant evolution.
- The application of systemic therapy in the neoadjuvant and adjuvant settings for soft tissue sarcoma requires further investigation.
- Current data on adjuvant chemotherapy efficacy remain inconclusive, necessitating careful consideration in clinical practice.
Purpose of the Study:
- To review the evolving landscape of systemic treatment for adult-type soft tissue sarcoma.
- To discuss the current evidence and clinical considerations for neoadjuvant and adjuvant chemotherapy.
- To highlight the established role of systemic therapy in advanced and metastatic disease management.
Main Methods:
- Review of current literature and clinical practice guidelines regarding systemic therapy for soft tissue sarcoma.
- Analysis of the experimental role of neoadjuvant chemotherapy.
- Evaluation of inconclusive data on adjuvant chemotherapy.
Main Results:
- Neoadjuvant chemotherapy for soft tissue sarcoma is currently considered experimental.
- Data supporting the use of adjuvant chemotherapy in soft tissue sarcoma are inconclusive.
- Systemic therapy is well-established for locally advanced and metastatic soft tissue sarcoma.
Conclusions:
- Neoadjuvant and adjuvant chemotherapy for soft tissue sarcoma should be considered on an individual basis following multidisciplinary team discussion.
- Histology-based treatment approaches are under active investigation for systemic therapy in soft tissue sarcoma.
- Ongoing research is crucial for refining treatment strategies in soft tissue sarcoma management.
More Related Videos
Related Concept Videos
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K